Recalls from Supernus Pharmaceuticals, Inc.

• Trokendi XR (Topiramate) Extended-Release Capsules (opens in a new tab)
  Low risk, FDA, Sep 3, 2026, Drug dissolving problem
• Trokendi XR, Topiramate Extended-Release Capsules (opens in a new tab)
  Low risk, FDA, Jul 17, 2026, Drug dissolving problem

Data: Recall Canary (opens in a new tab)